NCT07722559

Brief Summary

The goal of this clinical trial is to determine whether the addition of manual traction to a standard rehabilitation protocol improves early recovery after primary total knee arthroplasty (TKA) in women aged 50-75 years with knee osteoarthritis. The main questions it aims to answer are:

  • Does the addition of manual traction reduce postoperative pain during the first four weeks after TKA?
  • Does manual traction improve physical function, knee range of motion, patient-reported knee function, and health-related quality of life compared with standard rehabilitation alone?
  • Does manual traction reduce the need for analgesic medication during the early postoperative rehabilitation period? Researchers will compare participants receiving manual traction plus standard rehabilitation with participants receiving sham traction plus the same standard rehabilitation protocol to determine whether manual traction provides additional clinical benefits during early rehabilitation after TKA. Participants will:
  • Be randomly assigned to either the manual traction group or the sham traction (control) group.
  • Receive a standardized rehabilitation program for four weeks after surgery, with the intervention group receiving manual traction and the control group receiving sham traction.
  • Attend supervised rehabilitation sessions five times per week throughout the four-week intervention period.
  • Complete validated questionnaires assessing pain, knee function, joint awareness, and health-related quality of life at predefined assessment time points.
  • Undergo standardized clinical assessments of knee range of motion and physical function before surgery, before rehabilitation, during follow-up, and one month after surgery.
  • Have their analgesic medication use recorded throughout the rehabilitation period.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
4mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Jul 2026Nov 2026

First Submitted

Initial submission to the registry

July 16, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

July 22, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 23, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 22, 2026

Expected
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 12, 2026

Last Updated

July 23, 2026

Status Verified

July 1, 2026

Enrollment Period

3 months

First QC Date

July 16, 2026

Last Update Submit

July 21, 2026

Conditions

Keywords

Manual TractionQuality of lifeEarly rehabilitationStandard Rehabilitation protocolTotal Knee ArthroplastyPainFunction

Outcome Measures

Primary Outcomes (1)

  • Pain Intensity Measured by the Numeric Pain Rating Scale (NPRS)

    Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), an 11-point scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. Higher scores indicate worse pain.

    Baseline (preoperative) and weekly during the first four postoperative weeks (5 assessments).

Secondary Outcomes (8)

  • Physical Function Measured by the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS-JR)

    Pre-treatment and at the fourth postoperative week.

  • Knee range of motion

    Baseline (preoperative), pre-treatment, and at the fourth postoperative week.

  • Timed Up and Go Test (TUG)

    At the fourth postoperative week.

  • Joint Perception Measured by the Forgotten Joint Score-12 (FJS-12)

    At 4 weeks after surgery.

  • Health-Related Quality of Life Measured by the EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L)

    Before surgery (baseline) and at 4 weeks after surgery.

  • +3 more secondary outcomes

Study Arms (2)

Traction Group (TG)

EXPERIMENTAL

Participants assigned to this arm will receive manual tibiofemoral traction combined with a standardized rehabilitation program following total knee arthroplasty. Manual traction will be applied by a licensed physiotherapist using the Kaltenborn mobilization technique for three weeks, with progressive traction grades and force adjusted according to the study protocol and patient tolerance. The standardized rehabilitation program will include supervised therapeutic exercises targeting pain reduction, improvement of knee range of motion, muscle strength, functional mobility, gait, and overall postoperative recovery.

Procedure: Manual Tibiofemoral Traction

Control Group (CG)

SHAM COMPARATOR

Participants assigned to this arm will receive sham tibiofemoral traction combined with the same standardized rehabilitation program following total knee arthroplasty. Sham traction will replicate the positioning and therapist contact of the manual traction procedure without the application of therapeutic traction force, in order to maintain participant blinding. The standardized rehabilitation program will include supervised therapeutic exercises identical to those provided to the intervention group, targeting pain management, knee range of motion, muscle strength, functional mobility, gait, and postoperative recovery.

Procedure: Sham Tibiofemoral Traction

Interventions

Participants will receive manual tibiofemoral traction combined with a standardized rehabilitation program following total knee arthroplasty. During the first postoperative week, all participants will receive standard rehabilitation without traction. Manual traction will begin in the second postoperative week and will be applied by a physiotherapist using the Kaltenborn technique. The distal femur will be stabilized with a fixation belt, while a separate traction belt around the distal tibia and fibula will apply tibiofemoral traction with the knee in extension. Traction will progress over three weeks: Grade I in week 2 (10-15% body weight), Grade II in week 3 (15-20%), and Grade III in week 4 (20-25%). The traction grade and force will be adjusted according to patient tolerance and postoperative safety. Each session will include 30-60 seconds of traction followed by a 15-second rest interval, repeated for eight cycles. After each session, ROM (20 active,20 assisted) will be performed.

Traction Group (TG)

Participants assigned to the control group will receive sham tibiofemoral traction combined with the standardized rehabilitation program following total knee arthroplasty. Sham traction will simulate the manual traction procedure without the application of therapeutic traction force. The procedure will be performed to maintain participant blinding while providing the same rehabilitation protocol as the intervention group.

Control Group (CG)

Eligibility Criteria

Age50 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female patients aged between 50 and 75 years.
  • Patients who will undergo primary total knee arthroplasty due to osteoarthritis, classified as Kellgren-Lawrence grades 3 to 4.
  • Patients willing to participate in the study and able to provide informed consent.

You may not qualify if:

  • Morbid obesity, defined as a body mass index (BMI) greater than 40 kg/m².
  • Revision arthroplasty procedures.
  • Presence of severe cardiac, vascular, renal, neurological, psychiatric, or other orthopedic conditions affecting the lower limb and limiting functional abilities.
  • Active infections or contraindications to physical therapy.
  • Inability to comply with the prescribed rehabilitation protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Clinical Center of Kosovo (UCCK) - Clinic of Physical Medicine and Rehabilitation

Pristina, Pristina District, 10000, Kosovo

Location

MeSH Terms

Conditions

Osteoarthritis, KneePain

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • MIMOZE ZOGAJ, MSc

    Alma Mater Europaea - Slovenia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants and outcome assessors will be blinded to treatment allocation. Participant blinding will be maintained through the use of sham traction in the control group. Due to the nature of the intervention, the treating physiotherapist cannot be blinded and will not be involved in outcome assessment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned in a 1:1 ratio to one of two parallel groups. The intervention group will receive manual tibiofemoral traction combined with a standardized rehabilitation protocol, while the control group will receive sham traction combined with the same standardized rehabilitation protocol. Participants and outcome assessors will be blinded to group allocation; however, the treating physiotherapist cannot be blinded due to the nature of the intervention. The intervention will be administered over a three-week period, and outcomes will be assessed according to the predefined study schedule.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctoral Candidate

Study Record Dates

First Submitted

July 16, 2026

First Posted

July 23, 2026

Study Start

July 22, 2026

Primary Completion (Estimated)

October 22, 2026

Study Completion (Estimated)

November 12, 2026

Last Updated

July 23, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared because the study involves identifiable clinical data collected from human participants. Data will be protected to ensure participant confidentiality and privacy in accordance with ethical approval requirements and applicable data protection regulations. Only aggregated, de-identified study results will be reported in scientific publications.

Locations